42 Stocks Moving In Monday's Mid-Day Session

Gainers

  • Axsome Therapeutics, Inc. AXSM jumped 215 percent to $8.28 after the company disclosed that it has achieved its primary endpoint in its Phase 2 trial for major depressive disorder..
  • Luxoft Holding, Inc. LXFT climbed 81.4 percent to $57.50 after the company announced it is being acquired by DXC for $2 billion.
  • Loxo Oncology, Inc. LOXO gained 65.6 percent to $231.63 after the company received an acquisition offer from Eli Lilly LLY at $235/Share in cash.
  • Sage Therapeutics, Inc. SAGE gained 44.6 percent to $140.99 after the company disclosed that its SAGE-217 met its primary and secondary endpoints in its Phase 3 clinical trial in postpartum depression.
  • QEP Resources, Inc. QEP gained 43.1 percent to $8.70 after Elliott Management made an offer to acquire the company.
  • Insmed Incorporated INSM jumped 41.1 percent to $20.95 after climbing 6.76 percent on Friday.
  • Phunware Inc PHUN gained 35 percent to $73.00.
  • Taiwan Liposome Company, Ltd. TLC rose 28.3 percent to $7.70.
  • CLPS Inc CLPS gained 23.5 percent to $3.10.
  • Leap Therapeutics, Inc. LPTX surged 23.4 percent to $3.16.
  • ION Geophysical Corporation IO gained 23 percent to $7.38.
  • Roku, Inc. ROKU gained 22.4 percent to $41.21 after the company reported estimated Q4 active accounts have increased since last year and streaming hours are up 68%. The company also announced a partnership with Westinghouse.
  • Reata Pharmaceuticals, Inc. RETA rose 22 percent to $71.98. Reata Pharmaceuticals named Geoffrey A. Block, M.D., as Vice President, Nephrology.
  • Merus N.V. MRUS jumped 20.9 percent to $17.04 after reporting IND clearance for MCLA-145.
  • Lannett Company, Inc. LCI rose 20.4 percent to $7.31.
  • Calumet Specialty Products Partners, L.P. CLMT jumped 19.5 percent to $3.2025.
  • Selecta Biosciences, Inc. SELB rose 19 percent to $2.88.
  • ASV Holdings Inc ASV gained 18 percent to $3.15.
  • Clovis Oncology, Inc. CLVS jumped 17.3 percent to $21.51 after reporting product revenue for Q4 and 2018.
  • Blueprint Medicines Corporation BPMC gained 17.2 percent to $62.67.
  • Invitae Corporation NVTA surged 17.2 percent to $13.69 after reporting 2018 preliminary financial results.
  • Constellation Pharmaceuticals, Inc. CNST climbed 16.7 percent to $6.20.
  • Diversicare Healthcare Services, Inc. DVCR rose 15.1percent to $3.2352.
  • SilverSun Technologies, Inc. SSNT rose 15 percent to $2.2999.
  • Deciphera Pharmaceuticals, Inc. DCPH gained 14.4 percent to $24.57.
  • Neptune Wellness Solutions Inc. NEPT rose 13.5 percent to $3.28 after the company disclosed that it has received its Canada Cannabis license.
  • Exact Sciences Corporation EXAS rose 12.6 percent to $73.92 after the company issued strong revenue forecast.
  • Diebold Nixdorf, Incorporated DBD rose 11.8 percent to $2.94 after dropping 2.59 percent on Friday.
  • PhaseBio Pharmaceuticals, Inc. PHAS climbed 10.9 percent to $3.58.
  • Neurocrine Biosciences, Inc. NBIX gained 9.1 percent to $81.46 after the company announced it expects Q4 net product sales to have doubled since last year.
  • Arena Pharmaceuticals, Inc. ARNA gained 6.1 percent to $43.47.
  • General Electric Company GE shares rose 6 percent to $8.71 following reports that Apollo is considering GE's jet-leasing business.


Check out these big penny stock gainers and losers


Losers

  • Natural Health Trends Corp. NHTC fell 23.9 percent to $15.05. Natural Health Trends rejected false allegations in CCTV report and reiterated commitment to ethical business practices.
  • AxoGen, Inc. AXGN dropped 21.2 percent to $16.79. AxoGen expects Q4 sales of at least $23.4 million and FY18 sales of at least $83.9 million.
  • PG&E Corporation PCG dropped 20.6 percent to 19.36 after CNBC reported the company could face a minimum of $30 billion in liabilities related to California wildfires in 2017 and 2018, citing unnamed sources.The report comes after a Reuters story over the weekend suggested the utility is considering a bankruptcy filing and will potentially be taking a major financial charge in Q4.
  • Collegium Pharmaceutical, Inc. COLL shares dipped 19.4 percent to $15.09 after the company issued full-year 2019 guidance.
  • Cutera, Inc. CUTR dropped 18.2 percent to $13.85 after reporting resignation of CEO and President James Reinstein.
  • Maxar Technologies Ltd. MAXR fell 18.2 percent to $9.59 after the company reported failure of its WorldView-4 Satellite.
  • Hi-Crush Partners LP HCLP tumbled 15 percent to $3.6900 after the company reported Q4 sales volumes fell 29% Q/Q and suspended its quarterly distribution.
  • MOGU Inc. MOGU fell 11.2 percent to $18.82 after dropping 6.70 percent on Friday.
  • FTE Networks, Inc. FTNW dropped 11 percent to $3.3750.
  • Select Medical Holdings Corporation SEM fell 10.3 percent to $14.43.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasGeneralBiotechnologyHealth CareLosersTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!